Compare iShares Global Tech ETF (IXN) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Global Tech ETF vs Nuwellis Inc — how do they compare? iShares Global Tech ETF trades at $137.71, while Nuwellis Inc trades at $2.94 (market cap $1.09M). The key difference: iShares Global Tech ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| IXN | NUWE | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $149.74 | $527.46 |
52-Week Low | $94.04 | $2.80 |
Market Cap | — | $1.09M |
Enterprise Value | — | -$722.58K |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IXN trades at $132.95, up 0.25% on the day, with technical indicators showing a bearish trend from moving averages and a neutral stance from oscillators. The stock faces resistance near $134 and support at $132. Recent news highlights its strong tech exposure but cautions that valuations may already reflect high expectations.
The outlook for IXN is mixed, with opportunities in global tech leadership and AI-driven growth, but risks include stretched valuations and concentration in tech. Analyst sentiment leans cautious, emphasizing the need for clearer earnings growth or a more attractive entry point for investment.
NUWE trades at $3.00, up 5.26% over 24 hours, following a recent 35:1 reverse stock split effective June 26, 2026. The stock shows a bearish technical signal with all moving averages indicating sell. Fundamentally, the company reported a net loss of $17.52M in 2025, with negative profit margins, though revenue grew to $8.27M. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026.
Outlook remains challenging due to persistent losses and high cash burn, but strategic initiatives in pediatric cardiorenal care and new patents offer growth potential. Key risks include negative ROE, reliance on financing, and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid financial headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Global Tech ETF
IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.
Read more on IXN →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
